Solventum director granted 3,300 RSUs

WEILAND JOHN H reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 05/18/2026 - 05:36 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

WEILAND JOHN H reported acquisition or exercise transactions in this Form 4 filing.

Solventum Corp director John H. Weiland received a grant of 3,300 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive 1 share of Solventum common stock upon settlement. The RSUs will fully vest on May 15, 2027, if he continues serving through that date.

Insider Trade Summary

Grant/Award: 3,300 shares

Grant/Award 1 txn

Insider WEILAND JOHN H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	3,300	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 3,300 contracts (Direct)

Footnotes (2)

F1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2. The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

Key Figures

RSUs granted: 3,300 units RSUs after transaction: 3,300 units RSU-to-share ratio: 1 RSU : 1 share +1 more

4 metrics

RSUs granted 3,300 units Grant to director John H. Weiland

RSUs after transaction 3,300 units Total RSUs held following grant

RSU-to-share ratio 1 RSU : 1 share Each RSU represents one common share upon settlement

Vesting date May 15, 2027 Full vesting subject to continued service

Key Terms

Restricted Stock Units, contingent right, vest, Common Stock

4 terms

Restricted Stock Units financial

"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive 1 share of the issuer's Common Stock"

vest financial

"The RSUs shall fully vest on May 15, 2027, subject to continued service"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Common Stock financial

"receive 1 share of the issuer's Common Stock upon settlement"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Solventum Corp (SOLV) report for John H. Weiland?

Solventum Corp reported that director John H. Weiland received 3,300 Restricted Stock Units as a grant. These RSUs are a form of equity compensation that can convert into common stock if vesting conditions are satisfied over time.

How many Restricted Stock Units did the Solventum (SOLV) director receive?

John H. Weiland received 3,300 Restricted Stock Units from Solventum Corp. The grant increases his derivative equity-based holdings by this amount, with each RSU representing a right to receive one share of common stock at settlement if vesting is met.

When do John H. Weiland’s Solventum (SOLV) RSUs vest?

The 3,300 Restricted Stock Units granted to John H. Weiland are scheduled to fully vest on May 15, 2027. Vesting is conditioned on his continued service with Solventum Corp through that date, meaning unvested units could be forfeited if service ends earlier.

What does each Solventum (SOLV) RSU granted to John H. Weiland represent?

Each Restricted Stock Unit represents a contingent right to receive one share of Solventum’s common stock upon settlement. This means no shares are issued immediately; stock is delivered later if the vesting and service conditions described in the grant are satisfied.

Did John H. Weiland buy or sell Solventum (SOLV) shares in this Form 4?

The Form 4 shows an equity grant, not an open-market trade. John H. Weiland acquired 3,300 Restricted Stock Units as compensation, with no reported purchases or sales of Solventum common stock in the market connected to this particular filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WEILAND JOHN H

(Last)

(First)

(Middle)

1750 YANKEE DOODLE ROAD

(Street)

EAGAN

MINNESOTA

55121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	05/15/2026		A		3,300		⁽²⁾	⁽²⁾	Common Stock	3,300	$0	3,300	D

Explanation of Responses:

1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

2. The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

Remarks:

	/s/Megan Bombick, attorney-in-fact for John H. Weiland	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR